401
Views
6
CrossRef citations to date
0
Altmetric
Review

Current omics-based biomarkers for cholangiocarcinoma

, , , , &
Pages 997-1005 | Received 14 Jun 2019, Accepted 24 Sep 2019, Published online: 01 Oct 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yi Chen, Xiaoling Liu, Liyun Huang, Lihong Chen & Bin Wang. (2023) Clinicopathological, etiological and molecular characteristics of intrahepatic cholangiocarcinoma subtypes classified by mucin production and immunohistochemical features. Expert Review of Molecular Diagnostics 23:5, pages 445-456.
Read now

Articles from other publishers (5)

Hongmin Gao, Mengran Yang, Xueying Cao, Qin Liu & Peipei Xu. (2023) A high-level feature channel attention UNet network for cholangiocarcinoma segmentation from microscopy hyperspectral images. Machine Vision and Applications 34:5.
Crossref
Rocio I R Macias, Vincenzo Cardinale, Timothy J Kendall, Matias A Avila, Maria Guido, Cedric Coulouarn, Chiara Braconi, Adam E Frampton, John Bridgewater, Diletta Overi, Stephen P Pereira, Marco Rengo, Jakob N Kather, Angela Lamarca, Federica Pedica, Alejandro Forner, Juan W Valle, Eugenio Gaudio, Domenico Alvaro, Jesus M Banales & Guido Carpino. (2022) Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions. Gut, pages gutjnl-2022-327099.
Crossref
Jacek Baj, Łukasz Bryliński, Filip Woliński, Michał Granat, Katarzyna Kostelecka, Piotr Duda, Jolanta Flieger, Grzegorz Teresiński, Grzegorz Buszewicz, Marzena Furtak-Niczyporuk & Piero Portincasa. (2022) Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already Know. Cancers 14:6, pages 1493.
Crossref
Pedro M. Rodrigues, Arndt Vogel, Marco Arrese, Domingo C. Balderramo, Juan W. Valle & Jesus M. Banales. (2021) Next-Generation Biomarkers for Cholangiocarcinoma. Cancers 13:13, pages 3222.
Crossref
Andrés García-Sampedro, Pilar Acedo & Stephen P. Pereira. 2021. Diagnosis and Management of Cholangiocarcinoma. Diagnosis and Management of Cholangiocarcinoma 413 434 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.